BRAF Gene Mutation: Clinical Trials

3 trials for BRAF Gene Mutation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Terminated 3

Follow BRAF Gene Mutation: new trials by email Literature Review of BRAF Gene Mutation trials Research Report on BRAF Gene Mutation

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway
DCC-3084 - Advanced Solid Tumor, RAF Mutation
Phase 1TerminatedDeciphera Pharmaceuticals, LLC292024-05-142026-03-05
Study of IK-595 in RAS- or RAF-altered Advanced Tumors
IK-595 - Solid Tumor, Adult, Colorectal Cancer
Phase 1TerminatedIkena Oncology752023-12-182025-09-19
Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction
Dabrafenib, Laboratory Biomarker Analysis, Pharmacogenomic Study - BRAF Gene Mutation, Hepatic Complication
Phase 1TerminatedNational Cancer Institute (NCI)82013-08-232018-08-14

Narrower conditions

Carcinoma, Non-Small-Cell Lung (2)  ·  Melanoma (2)  ·  Colorectal Neoplasms (1)  ·  Glioma (1)  ·  Pancreatic Neoplasms (1)  ·  Renal Insufficiency (1)  ·  Thyroid Neoplasms (1)

Broader conditions

Bronchial Neoplasms (2)  ·  Carcinoma, Bronchogenic (2)  ·  Lung Diseases (2)  ·  Lung Neoplasms (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Neuroectodermal Tumors (2)  ·  Neuroendocrine Tumors (2)  ·  Nevi and Melanomas (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Neoplasms (2)  ·  Skin Diseases (2)

Interventions

Pharmacogenomic Testing (1)  ·  dabrafenib (1)

Sponsors

Deciphera Pharmaceuticals, LLC (1)  ·  Ikena Oncology (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (3)  ·  Canada (1)

Top investigators

Caroline Germa, MD (1)  ·  Ramesh Ramanathan (1)

NIH funding

P30CA015083 (1), U01CA062490 (1), U01CA069912 (1), U01CA132123 (1), UM1CA186644 (1), UM1CA186686 (1), UM1CA186690 (1), UM1CA186691 (1), UM1CA186709 (1), UM1CA186716 (1), UM1CA186717 (1)